Regulations.gov document
Discussion of Appropriate Testing Procedures for Exocrine Pancreatic Insufficiency Drug…
Notice · FDA-1979-N-0029 · posted Mar 23, 1992
Key facts
| Document ID | FDA-1979-N-0029-0012 |
|---|---|
| Title | Discussion of Appropriate Testing Procedures for Exocrine Pancreatic Insufficiency Drug Products; Workshop and Reopening of the Administrative Record |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-1979-N-0029 |
| Posted | Mar 23, 1992 |
| Federal Register citation | 57 FR 8586 |
| FR document number | 92-5691 |
| CFR | 21 CFR Parts 310 and 357 |
| Comment period opens | Mar 23, 1992 |
| Comments due | Jul 24, 1992 |
| Effective date | Mar 4, 1992 |
At a glance
- 10–99 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: